These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 13889401)

  • 21. [The treatment of hemophilia A with a new antihemophilic fraction "AHF SRK (human)". Comparison with the antihemophilic globulin AHG SRK].
    Duckert F; Müller G; Meili EO
    Schweiz Med Wochenschr; 1971 Dec; 101(50):1831-8. PubMed ID: 5173501
    [No Abstract]   [Full Text] [Related]  

  • 22. [Activation of the antihemophilic globulin A (factor VIII). 2. Effect of ampholine on the course of blood coagulation and the molecular conformation of factor VIII].
    Liebe S
    Z Gesamte Inn Med; 1982 Feb; 37(4):110-6. PubMed ID: 6805144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Blood coagulation changes due to deficiency of antihemophilic factor (factor VIII)].
    GORZKOWSKI T; WIERZBOWSKA A
    Minerva Med; 1958 Jul; 49(53):2645-6. PubMed ID: 13577546
    [No Abstract]   [Full Text] [Related]  

  • 24. MODERN ASPECTS OF THE TREATMENT OF HEMOPHILIA. III.
    VANCREVELD S; MOCHTAR IA; KOPPE JG
    Can Med Assoc J; 1964 May; 90(22):1248-9. PubMed ID: 14158954
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Separation of human antihemophilic factor (AHF, factor VIII) from fibrinogen by means of defibrase.
    Lopaciuk S; Latallo ZS; Bykowska K; Daszynski J
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1975; 102(6):671-8. PubMed ID: 54318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [EXPERIMENTS CONCERNING FACTOR 8. LONGEVITY OF FACTOR 8 IN VIVO AND VITRO AND THE SUBFRACTIONATION OF FIBRINOGEN SAMPLES FROM 2 DONORS].
    MOCHTAR IA; KOPPE JG; STIBBE J
    Maandschr Kindergeneeskd; 1964 Jul; 32():440-5. PubMed ID: 14228685
    [No Abstract]   [Full Text] [Related]  

  • 27. [Hemophilia. Recent investigations on factor VIII (antihemophilic factor)].
    PAVLOVSKY A
    Prensa Med Argent; 1960 May; 47():1511-5. PubMed ID: 13733615
    [No Abstract]   [Full Text] [Related]  

  • 28. [Study of the determination of antihemophilic factor A (factor VIII) by the thromboplastin generation test].
    MORATI-SCHMITT M; DENHAUT G; GAUCHERAND O; REVOL L
    Hemostase; 1961; 1():365-72. PubMed ID: 14475808
    [No Abstract]   [Full Text] [Related]  

  • 29. Role of fibrinogen-, factor VIII- and XIII-mediated clot propagation in gelatin haemodilution.
    Schramko AA; Kuitunen AH; Suojaranta-Ylinen RT; Niemi TT
    Acta Anaesthesiol Scand; 2009 Jul; 53(6):731-5. PubMed ID: 19239406
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [THE SUPPLY OF PERSONALLY PREPARED PLASMA FRACTIONS IN HEMOPHILIA A].
    GAERISCH F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1963; 81():148-55. PubMed ID: 14165084
    [No Abstract]   [Full Text] [Related]  

  • 31. [Purification of antihemophilic factor VIII (AHF)].
    SIMONETTI C; CASILLAS G; PAVLOVSKY A
    Hemostase; 1961; 1():57-61. PubMed ID: 13913161
    [No Abstract]   [Full Text] [Related]  

  • 32. Coagulation factor VIII activity in diabetic patients.
    Babić N; Dervisević A; Huskić J; Musić M
    Med Glas (Zenica); 2011 Feb; 8(1):134-9. PubMed ID: 21263411
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [THE CONSUMPTION OF ANTIHEMOPHILIC GLOBULIN (FACTOR VIII) DURING COAGULATION OF THE BLOOD IN NORMAL AND PATHOLOGICAL CONDITIONS].
    ASCARI E; BARBIERI U; GOBBI F
    Prog Med (Napoli); 1963 Jan; 19():37-43. PubMed ID: 14125587
    [No Abstract]   [Full Text] [Related]  

  • 34. Fibrinogen derived inhibitors of blood coagulation.
    KOWALSKI E
    Thromb Diath Haemorrh; 1960; 4(Suppl)():211-23. PubMed ID: 13753710
    [No Abstract]   [Full Text] [Related]  

  • 35. FURTHER STUDIES ON THE EFFECT OF DEXTRAN OF VARIOUS MOLECULAR WEIGHT ON THE COAGULATION MECHANISM.
    NILSSON IM; EIKEN O
    Thromb Diath Haemorrh; 1964 Apr; 11():38-50. PubMed ID: 14167114
    [No Abstract]   [Full Text] [Related]  

  • 36. [ON THE TEMPERATURE FACTOR IN THE TRANSFORMATION OF FIBRINOGEN INTO FIBRIN].
    BELITSER VA; VARETSKAIA TV; GRIAZNUKHINA EA
    Acta Biol Med Ger; 1963; 11():730-5. PubMed ID: 14121869
    [No Abstract]   [Full Text] [Related]  

  • 37. [Studies on blood coagulation. I. Factors involved in the conversion of prothrombin into thrombin and of fibrinogen into fibrin].
    LONG LA; COLPRON G
    Union Med Can; 1961 Jan; 90():22-9. PubMed ID: 13763333
    [No Abstract]   [Full Text] [Related]  

  • 38. The reducing properties of fibrinogen; the role of SH groups in the clotting of fibrinogen.
    BAGDY D; GUBA F
    Hung Acta Physiol; 1948; 1(6):197-210. PubMed ID: 18894927
    [No Abstract]   [Full Text] [Related]  

  • 39. A STUDY OF THE COAGULANT ACTION OF EIGHT SNAKE VENOMS.
    NAHAS L; MACFARLANE RG; DENSON KW
    Thromb Diath Haemorrh; 1964 Dec; 12():355-67. PubMed ID: 14254694
    [No Abstract]   [Full Text] [Related]  

  • 40. FIBRINOGEN DERIVED COAGULATION INHIBITORS IN OBSTETRIC CASES OF ACUTE FIBRINOLYSIS.
    ROSZKOWSKI I; NIEWIAROWSKA M; BAR-PRATKOWSKA J
    Thromb Diath Haemorrh; 1965 Mar; 13():25-34. PubMed ID: 14285974
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.